Anti-Cancer Medicines Availability Study
Study objectives: to provide health authorities with data on the availability of licensed anti-neoplastic medicines in Europe and worldwide
The International study was launched in 2015 and the results will be published shortly.
- to provide health authorities with data on the availability of licensed anti-neoplastic medicines
- to report on the actual availability of anti-neoplastic medicines to patients when they are prescribed and when patients can afford them
- to provide data so that policy makers can decide how to best address and resolve the challenges identified